[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lyn H. Jones<\/i><\/u><\/presenter>. Dana-Farber Cancer Institute, Boston, MA","CSlideId":"","ControlKey":"3a1cd1e3-5561-4dd2-b0d2-3d89225a9f5e","ControlNumber":"1483","DisclosureBlock":"&nbsp;<b>&nbsp;L.H. Jones:<\/b>  ; Ananke Therapeutics. ; Interline Therapeutics. ; Jnana Therapeutics. ; Matchpoint Therapeutics. ; Rapafusyn Pharmaceuticals.","End":"4\/15\/2023 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"493","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lyn Jones, PhD","PresenterKey":"1f7d3501-09e0-4c04-bab6-09a4592aff94","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lyn H. Jones<\/i><\/u><\/presenter>. Dana-Farber Cancer Institute, Boston, MA","CSlideId":"","ControlKey":"b6f729e9-8d71-481f-a30b-0891909d7423","ControlNumber":"10491","DisclosureBlock":"<b>&nbsp;L. H. Jones, <\/b> <br><b>Ananke Therapeutics<\/b> I, S. <br><b>Interline Therapeutics<\/b> I, S. <br><b>Jnana Therapeutics<\/b> S. <br><b>Matchpoint Therapeutics<\/b> I. <br><b>Rapafusyn Pharmaceuticals<\/b> I, S.","End":"4\/15\/2023 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"9520","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lyn Jones, PhD","PresenterKey":"1f7d3501-09e0-4c04-bab6-09a4592aff94","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chair Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chair Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lyn H. Jones<\/i><\/u><\/presenter>. Dana-Farber Cancer Institute, Boston, MA","CSlideId":"","ControlKey":"71db15eb-bcae-4aca-9651-5a60b6602708","ControlNumber":"1484","DisclosureBlock":"<b>&nbsp;L. H. Jones, <\/b> <br><b>Ananke Therapeutics<\/b> I, S. <br><b>Interline Therapeutics<\/b> I, S. <br><b>Jnana Therapeutics<\/b> S. <br><b>Matchpoint Therapeutics<\/b> I. <br><b>Rapafusyn Pharmaceuticals<\/b> I, S.","End":"4\/15\/2023 10:21:00 AM","HasWebcast":null,"Highlights":[],"Id":"494","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lyn Jones, PhD","PresenterKey":"1f7d3501-09e0-4c04-bab6-09a4592aff94","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Emerging opportunities for non-degrading molecular superglues","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 10:01:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Emerging opportunities for non-degrading molecular superglues","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"cc30944b-8216-4099-8181-94039ac98899","ControlNumber":"8689","DisclosureBlock":"","End":"4\/15\/2023 10:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"1178","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 10:21:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Matthew D. Disney<\/i><\/u><\/presenter>. The Scripps Research Institute, Juniper, FL","CSlideId":"","ControlKey":"58b11414-7340-41df-a85a-fb1712cb508b","ControlNumber":"2281","DisclosureBlock":"<b>&nbsp;M. D. Disney, <\/b> <br><b>ExpansionTherapeutics<\/b> S.","End":"4\/15\/2023 10:50:00 AM","HasWebcast":null,"Highlights":[],"Id":"652","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Matthew Disney, PhD","PresenterKey":"5bfcc4e0-5158-4d42-b2ea-f8ce574bcacc","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Sequence-based design of small molecule RNA degraders","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 10:30:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Sequence-based design of small molecule RNA degraders","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"6c400c10-185e-4da0-9602-10b146f47cf5","ControlNumber":"8690","DisclosureBlock":"","End":"4\/15\/2023 11:00:00 AM","HasWebcast":null,"Highlights":[],"Id":"1179","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 10:50:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Heidi Greulich<\/i><\/u><\/presenter>. Broad Institute, Cambridge, MA","CSlideId":"","ControlKey":"2177b250-8841-48ed-9530-bcd7fdf8825a","ControlNumber":"2336","DisclosureBlock":"<b>&nbsp;H. Greulich, <\/b> <br><b>Bayer Healthcare<\/b> G. <br><b>Patent<\/b> P.","End":"4\/15\/2023 11:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"666","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Heidi Greulich, PhD","PresenterKey":"d7895d78-26da-4942-9b3c-956cd2d8a8e6","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Mechanism of action of velcrin small molecules","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 11:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Mechanism of action of velcrin small molecules","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"d2237407-e8ac-471e-b8a7-9bb9a632e724","ControlNumber":"8691","DisclosureBlock":"","End":"4\/15\/2023 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"1180","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 15 2023 10:00AM","SessionId":"137","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic: Part 2 of 3: Leveraging Induced Proximity - Beyond Targeted Protein Degradation","ShowChatLink":"false","Start":"4\/15\/2023 11:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]